Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice

Visit https://www.peervoice.com/MZH860 to view the entire programme with slides. After completing “Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice”, participants will be able to: Define the treatable characteristics in asthma and chronic rhinosinusitis with nasal polyps (CRSwNP); Describe the potential consequences of not achieving treatment goals; Summarise how patients with moderate-severe asthma and/or CRSwNP should be monitored; Identify the patient and disease characteristics that would indicate that a patient may benefit from biologic therapy; Assess the impact of attaining treatment goals on clinical practice.